Albemarle Corporation

Albemarle Corporation develops, manufactures, and markets highly engineered specialty chemicals around the world. The company focuses on lithium compounds, bromine-based products, and refining catalysts. With a history dating back to 1887, Albemarle was incorporated in 1994 and has its headquarters in Charlotte, North Carolina. Albemarle's products are used in a wide range of products, ranging from pharmaceuticals to cleaning, water treatment, agricultural, electronic, paper, and photographic products. The company operates its business through three segments, including Lithium, Bromine Specialties, and Catalysts. Albemarle's Lithium segment develops and manufactures lithium-based compounds, value-added lithium specialties, and reagents. The Bromine Specialties segment is focused on fire safety solutions and other specialty chemicals applications. The company's Catalysts segment manufactures three main product lines: performance catalyst solutions (PCS); fluidized catalytic cracking (FCC) catalysts and additives; and Clean Fuels Technologies, which includes hydroprocessing catalysts (HPC) and isomerization and akylation catalysts. Available on the NYSE, Albemarle stock is listed under the ticker ALB. As of December 2021, the company employs approximately 5,400 people and serves clients in around 100 countries. On 30 September 2021, Albemarle announced reaching an agreement with Guangxi Tianyuan New Energy Materials Co., Ltd., a China-based lithium converter, to acquire all outstanding equity in the company for approximately $200m. Follow ALB share price movements by adding it to your eToro watchlist.